In the current study, cathepsin B ameliorated the thickening of the submesothelial layer in a peritoneal fibrosis mouse model and its inhibitor, cystatin C, attenuated the effect of cathepsin B, suggesting a possible role for cathepsin B in reducing peritoneal fibrosis in patients receiving PD. Here, CTSB is linked to Peritoneal Fibrosis.